Site-specific antioxidative therapy for prevention of atherosclerosis and cardiovascular disease

10Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Oxidative stress has been implicated in pathophysiology of aging and age-associated disease. Antioxidative medicine has become a practice for prevention of atherosclerosis. However, limited success in preventing cardiovascular disease (CVD) in individuals with atherosclerosis using general antioxidants has prompted us to develop a novel antioxidative strategy to prevent atherosclerosis. Reducing visceral adipose tissue by calorie restriction (CR) and regular endurance exercise represents a causative therapy for ameliorating oxidative stress. Some of the recently emerging drugs used for the treatment of CVD may be assigned as site-specific antioxidants. CR and exercise mimetic agents are the choice for individuals who are difficult to continue CR and exercise. Better understanding of molecular and cellular biology of redox signaling will pave the way for more effective antioxidative medicine for prevention of CVD and prolongation of healthy life span. © 2013 Hajime Otani.

Cite

CITATION STYLE

APA

Otani, H. (2013). Site-specific antioxidative therapy for prevention of atherosclerosis and cardiovascular disease. Oxidative Medicine and Cellular Longevity. https://doi.org/10.1155/2013/796891

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free